Characteristics of polycystic ovary syndrome rat models induced by letrozole, testosterone propionate and high-fat diets
- PMID: 39626468
- DOI: 10.1016/j.rbmo.2024.104296
Characteristics of polycystic ovary syndrome rat models induced by letrozole, testosterone propionate and high-fat diets
Abstract
Research question: What are the long-term effects of different models of polycystic ovary syndrome (PCOS), and which model could be used in future research?
Design: PCOS models induced by letrozole, letrozole plus high-fat diet (LE+HFD), testosterone propionate (TP) or testosterone propionate plus HFD (TP+HFD) were established in rats. Body weight, energy intake, blood glucose, sex hormone concentrations, lipid profiles and the oestrus cycle were observed. Histology of ovaries, large intestine and fat was displayed. Protein and mRNA levels relating to hormone synthesis, oocyte maturation, the gut barrier, lipid metabolism and inflammation were evaluated using western blotting, immunohistochemistry and PCR. The composition of the microbial community was measured using 16S RNA sequencing.
Results: Letrozole treatment induced hyperandrogenaemia, polycystic ovarian morphology, a disrupted oestrus cycle and impaired ovarian function, which could be restored within 42 days. Concurrently, letrozole disturbed glucose, fat, and energy metabolism, affected the inflammatory state and compromised intestinal homeostasis. HFD could amplify the disturbances in the metabolism and intestinal microenvironment, and the pituitary-ovarian axis was more efficiently and consistently affected by testosterone propionate. Testosterone propionate and TP+HFD treatment also disturbed the intestinal microenvironment. Although the metabolic effects of testosterone propionate were not as profound as those of letrozole, they were enhanced by HFD.
Conclusions: Letrozole is useful for studies on metabolic disturbances in PCOS, and LE+HFD treatment is suitable for investigations on PCOS metabolic abnormalities and the gut-PCOS link. Testosterone propionate injection is appropriate for studying reproductive abnormalities in PCOS, while TP+HFD treatment is the most comprehensive for studying PCOS reproductive abnormalities, metabolic disturbances and the gut-PCOS link.
Keywords: High-fat diet; Letrozole; Polycystic ovary syndrome; Rat models; Testosterone propionate.
Copyright © 2024 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Evaluation of representativeness and sustainability of PCOS rat models induced by letrozole with or without high-fat diet.Sci Rep. 2025 Aug 21;15(1):30754. doi: 10.1038/s41598-025-15026-4. Sci Rep. 2025. PMID: 40841528 Free PMC article.
-
Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.Steroids. 2024 Jun;206:109424. doi: 10.1016/j.steroids.2024.109424. Epub 2024 Apr 19. Steroids. 2024. PMID: 38642598
-
Letrozole Rat Model Mimics Human Polycystic Ovarian Syndrome and Changes in Insulin Signal Pathways.Med Sci Monit. 2020 Jul 8;26:e923073. doi: 10.12659/MSM.923073. Med Sci Monit. 2020. PMID: 32638705 Free PMC article.
-
Pancreastatin inhibitor PSTi8 improves ovarian health in Letrozole-HFD induced PCOS rats by ameliorating metabolic and reproductive parameters.Steroids. 2025 Feb;214:109558. doi: 10.1016/j.steroids.2024.109558. Epub 2024 Dec 30. Steroids. 2025. PMID: 39742935
-
Autoantibodies Targeting the Hypothalamic-Pituitary-Ovarian Axis in Polycystic Ovary Syndrome: Emerging Key Players in Pathogenesis?Int J Mol Sci. 2025 Apr 26;26(9):4121. doi: 10.3390/ijms26094121. Int J Mol Sci. 2025. PMID: 40362363 Free PMC article. Review.
Cited by
-
Metformin-mediated intestinal AMPK activation ameliorates PCOS through gut microbiota modulation and metabolic pathways.Front Endocrinol (Lausanne). 2025 Feb 18;16:1526109. doi: 10.3389/fendo.2025.1526109. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40041289 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical